| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.600 | None | 0.960 | 1 | 0 | 1993 | 2020 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.600 | None | 0.958 | 1 | 0 | 2003 | 2020 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1984 | 2007 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2010 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2020 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 0.981 | 1 | 0 | 2004 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.300 | None | 0.952 | 1 | 0 | 2008 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.300 | None | 0.965 | 1 | 0 | 1999 | 2020 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.300 | None | 0.973 | 1 | 0 | 1998 | 2020 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
opioid receptor delta 1 | 0.604 | 0.731 | 3.3E-03 |
|
phenotype | 0.290 | None | 1.000 | 1 | 0 | 2003 | 2020 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
phenotype | 0.280 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
C-C motif chemokine receptor 2 | 0.418 | 0.846 | 2.3E-02 |
|
phenotype | 0.270 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
phenotype | 0.260 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
phenotype | 0.260 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
phenotype | 0.250 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2008 | 2019 |